Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
Leyes y legislación
194
Historia
147
Política y gobierno
74
Impuestos
68
Impuestos sobre la renta
41
Derecho fiscal
26
Derecho civil
25
Industria de la construcción
16
Condiciones económicas
15
Seguridad social
15
Derecho constitucional
13
Democracia
12
Derecho laboral
12
Condiciones sociales
11
México
11
Elecciones
10
Legislación
9
Partidos políticos
9
Regulación del comercio exterior
9
Colonias
8
Derecho administrativo
8
Educación
8
Historia constitucional
8
Impuesto sobre el valor agregado
8
Agricultura
7
Aranceles de aduana
7
Causas
7
Derecho
7
Función pública
7
Impuesto al valor agregado
7
-
59421por Gopalan, Narendran, Srinivasalu, Vignes Anand, Chinnayan, Ponnuraja, Velayutham, Banurekha, Bhaskar, Adhin, Santhanakrishnan, Ramesh, Senguttuvan, Thirumaran, Rathinam, Sridhar, Ayyamperumal, Mahilmaran, Satagopan, Kumar, Rajendran, Dhanalakshmi, Manoharan, Tamizhselvan, Lakshmanan, Sekar, Paramasivam, Paulkumaran, Angamuthu, Dhanalakshmi, Ganesan, Mangalambal, Easudoss Arockia, John Washington, Venkatesan, Ramesh Babu, Lakshmipathy, Venkatesan, Shanmugham, Shivakumar, Subramanyam, Balaji, Shankar, Shakila, Mohideen Shaheed, Jawahar, Dhanaraj, Baskaran, Paranji Ramiyengar, Narayanan, Swaminathan, Soumya, Chandrasekaran, Padmapriyadarsini“…These parameters may potentially take up key positions as stratification factors for future trials contemplating on shorter TB regimens.…”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
59422por Kumar, Aarti, Mishra, Shambhavi, Singh, Shambhavi, Ashraf, Sana, Kan, Peiyi, Ghosh, Amit Kumar, Kumar, Alok, Krishna, Raghav, Stevenson, David K., Tian, Lu, Elias, Peter M., Darmstadt, Gary L., Kumar, Vishwajeet“…Further research is recommended to develop and evaluate therapeutic regimens and continuum of care delivery strategies for emollient therapy for newborn infants at highest risk of compromised skin barrier function. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
59423por Di Muzio, Nadia Gisella, Deantoni, Chiara Lucrezia, Brombin, Chiara, Fiorino, Claudio, Cozzarini, Cesare, Zerbetto, Flavia, Mangili, Paola, Tummineri, Roberta, Dell’Oca, Italo, Broggi, Sara, Pasetti, Marcella, Chiara, Anna, Rancoita, Paola Maria Vittoria, Del Vecchio, Antonella, Di Serio, Mariaclelia Stefania, Fodor, Andrei“…SIMPLE SUMMARY: Several phase III randomized trials of moderate hypofractionation, including a higher proportion of high-risk prostate cancer patients treated only to the prostate, failed to demonstrate the superiority of hypofractionated regimens. There is only one randomized phase III trial, of moderately hypofractionated high-dose radiotherapy to the prostate-only versus pelvic irradiation and prostate boost, with a sufficiently long follow-up. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
59424por Askar, Mostafa A., Thabet, Noura M., El-Sayyad, Gharieb S., El-Batal, Ahmed I., Abd Elkodous, Mohamed, El Shawi, Omama E., Helal, Hamed, Abdel-Rafei, Mohamed K.“…Due to the late manifestation of symptoms, rigorous treatment regimens are required following diagnosis. Existing treatments are limited by a lack of specificity, systemic toxicity, temporary remission, and radio-resistance in BC. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
59425por Li, Ning, Zhu, Yuan, Liu, Lu-Ying, Feng, Yan-Ru, Wang, Wen-Ling, Wang, Jun, Wang, Hao, Li, Gao-Feng, Tang, Yuan, Hu, Chen, Liu, Wen-Yang, Ren, Hua, Wang, Shu-Lian, Wang, Wei-Hu, Song, Yong-Wen, Liu, Yue-Ping, Fang, Hui, Tang, Yu, Lu, Ning-Ning, Chen, Bo, Qi, Shu-Nan, Liu, Xin-Fan, Li, Ye-Xiong, Jin, Jing“…Addition of oxaliplatin to 5-FU or capecitabine elicited similar outcomes but with significantly increased toxic effects; however, there is a need for randomized clinical trials comparing 2 CRT regimens for patients receiving CRT in the adjuvant setting. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
59426“…The exposure thresholds defined in this study will be useful in designing optimal MIN dosing regimens for treating STM infections and re-assessment of the current susceptibility breakpoint. …”
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
59427“…Conclusion: The CPCS was effective in resolving drug-related problems and in improving patients’ medication regimens, medication adherence, and QoL through patient education and dosage adjustments. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
59428por Young, Nicole, Bowman, Alison, Swedin, Kjell, Collins, James, Blair-Stahn, Nathaniel D., Lindstedt, Paulina A., Troeger, Christopher, Flaxman, Abraham D.“…However, few studies have compared the cost-effectiveness of different supplementation regimens. We compared the cost-effectiveness of MMS and BEP with IFA to quantify their benefits in 4 countries with considerable prevalence of maternal undernutrition. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
59429por Sidbury, Robert, Alpizar, Sady, Laquer, Vivian, Dhawan, Sunil, Abramovits, William, Loprete, Luca, Krishnaswamy, Jayendar Kumar, Ahmad, Faiz, Jabbar-Lopez, Zarif, Piketty, Christophe“…The popPK and PK/PD analyses confirmed that model-predicted exposure and efficacy of nemolizumab were similar in adolescents compared to adults receiving the same dosing regimens. Age did not impact PK parameters, while the main source of PK variability was body weight. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
59430por Jacomet, Christine, Goncalves, Émilie, Lambert, Céline, Chedorge, Didier, Puglièse-Wehrlen, Sylvia, Billaud, Éric, Zucman, David, Simon, Anne, Arvieux, Cédric, Trout, Hervé, Laurandin, Bruno, Maarek, René, Raymond, Isabelle, Puglièse, Pascal, Langlois, Julie, Certain, Agnès“…Patients who were less likely to endorse 90-D were those who consult in a city located outside the 3 French high HIV prevalence regions (OR 0.66 [0.44–0.99]), receive 2 vs 1 pill QD regimens (OR 0.53 [0.31–0.91]), and anticipate at least one vs no limitation to 90D (OR 0.27 [0.17–0.42]). 90D was perceived as possible by 152 pharmacists (86.4%), including 8 (5%) without restriction, and 219 doctors (99.6%), including 42 (19.2%) regardless of PLHIV’s immunovirologic status or social conditions (health insurance coverage, access to housing or accommodation, access to rights, resources). …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
59431por Menni, Cristina, May, Anna, Polidori, Lorenzo, Louca, Panayiotis, Wolf, Jonathan, Capdevila, Joan, Hu, Christina, Ourselin, Sebastien, Steves, Claire J, Valdes, Ana M, Spector, Tim D“…However, uncertainty remains over how long primary vaccination series remain effective, the ideal timing for booster doses, and the safety of heterologous booster regimens. We aimed to investigate COVID-19 primary vaccine series effectiveness and its waning, and the safety and effectiveness of booster doses, in a UK community setting. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
59432por Desmecht, Salomé, Tashkeev, Aleksandr, El Moussaoui, Majdouline, Marechal, Nicole, Perée, Hélène, Tokunaga, Yumie, Fombellida-Lopez, Celine, Polese, Barbara, Legrand, Céline, Wéry, Marie, Mni, Myriam, Fouillien, Nicolas, Toussaint, Françoise, Gillet, Laurent, Bureau, Fabrice, Lutteri, Laurence, Hayette, Marie-Pierre, Moutschen, Michel, Meuris, Christelle, Vermeersch, Pieter, Desmecht, Daniel, Rahmouni, Souad, Darcis, Gilles“…It may have implications for personalizing mRNA vaccination regimens used to prevent severe COVID-19 and reduce the impact of the pandemic on the healthcare system. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
59433“…The incidence of adverse events associated with the two regimens did not significantly differ (P-CABs vs. PPIs: 33.6% vs. 40.0%; RR [95% CI] = 0.84 [0.71‒1.00], p = 0.05). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
59434por Liu, Li-Hua, Yan, Mao-Hui, Di, Yu-Peng, Fu, Zhi-Guang, Zhang, Xiao-Dan, Li, Hong-Qi“…It is important to explore how elderly EC patients benefit from radical radiochemotherapy regimens, including the target area of radiotherapy (RT), radiation dose and fraction, and choice of chemotherapy drugs. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
59435por Kumara, Sagara N., Parkinson, Tim J., Laven, Richard A., Waghorn, Garry C., Pushpakumara, Anil, Donaghy, Daniel J.“…The aim of this study was to catalogue the availability, quantity, and composition of feeds, to identify the feeding regimens used, and to calculate dietary metabolisable energy (ME) and crude protein (CP) in order to investigate shortfalls in dietary requirements. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
59436por Mbangiwa, Tshepiso, Sturny-Leclère, Aude, Lechiile, Kwana, Kajanga, Cheusisime, Chammard, Timothée Boyer, Lortholary, Olivier, Dromer, Francoise Dromer, Hoving, Jennifer C., Lawrence, David S., Mwandumba, Henry, Mosepele, Mosepele, Harrison, Tom, Jarvis, Joseph N, Alanio, Alexandre“…The fungal load at D0 was significantly higher in patients who died at week 2 (w2) and at week 10 (w10) as compared with patients who survived post-week 10 (P <.01), with no significant difference in initial fungal load in both treatment regimens (P >.05). Detection of Cryptococcus DNA (28S rRNA qPCR) in plasma or whole blood within the first 24 h of treatment was significantly associated with early mortality at w2 and mortality at w10 (P <.01). …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
59437por Azar, Ibrahim, Yazdanpanah, Omid, Jang, Hyejeong, Austin, Adam, Kim, Seongho, Chi, Jie, Alkassis, Samer, Saha, Biplab K., Chopra, Amit, Neu, Kristoffer, Mehdi, Syed, Mamdani, Hirva“…The backbone of chemotherapy regimens in both is a platinum-etoposide doublet: cisplatin is traditionally the preferred platinum agent in the curative intent setting, whereas carboplatin is preferred in ES-SCLC because of its favorable toxicity profile. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
59438por Arner, Brooke E, Levine, Jordan A, Miller, Emily K, Patel, Tushar P, Jain, Arad, Gupta, Suryaa, Roberson, Robin B, Demidowich, Andrew P, Yanovski, Jack A“…Thus, we examined anti-inflammatory and metabolic effects of two commonly employed dosing regimens of colchicine, 0.2 mg/kg and 0. 02mg/kg, in a high-fat diet (HFD; 45%) mouse obesity model. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
59439por Jacobsohn, Tamar, Nguyen, Brian, Fernando, Frances, Brown, Jill, Blithe, Diana, Lee, Min, Yuen, Fiona, Swerdloff, Ronald, Liu, Peter, Wang, Christina, Farrant, Maritza, Anawalt, Bradley, Thirumalai, Arthi, Bremner, William, Page, Stephanie, Amory, John“…In placebo-controlled trials, men randomized to use active, daily oral progestogenic androgen prodrugs reported greater acceptability with their respective regimens than did men who received placebo pills despite low serum testosterone levels. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
59440por Auchus, Richard, Chan, Jean, Farber, Robert, Fechner, Patricia, Giri, Nagdeep, Nokoff, Natalie, Roberts, Eiry, Sarafoglou, Kyriakie, Sturgeon, Julia, Vogiatzi, Maria, Newfield, Ron“…The participants’ glucocorticoid and fludrocortisone regimens were maintained stable during crinecerfont treatment. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Online Artículo Texto